Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · Real-Time Price · USD
3.870
+0.010 (0.26%)
At close: Nov 20, 2024, 4:00 PM
3.690
-0.180 (-4.65%)
After-hours: Nov 20, 2024, 7:44 PM EST
Qualigen Therapeutics Market Cap
Qualigen Therapeutics has a market cap or net worth of $2.09 million as of November 21, 2024. Its market cap has decreased by -40.24% in one year.
Market Cap
2.09M
Enterprise Value
3.14M
1-Year Change
-40.24%
Ranking
Category
Stock Price
$3.87
Market Cap Chart
Since June 24, 2015, Qualigen Therapeutics's market cap has decreased from $38.40M to $2.09M, a decrease of -94.55%. That is a compound annual growth rate of -26.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 2.80M | - |
| Dec 29, 2023 | 2.80M | -48.15% |
| Dec 30, 2022 | 5.40M | -82.69% |
| Dec 31, 2021 | 31.20M | -55.04% |
| Dec 31, 2020 | 69.40M | 3,982.35% |
| Dec 31, 2019 | 1.70M | -50.00% |
| Dec 31, 2018 | 3.40M | -79.14% |
| Dec 29, 2017 | 16.30M | -43.99% |
| Dec 30, 2016 | 29.10M | 120.45% |
| Dec 31, 2015 | 13.20M | -65.63% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fresh2 Group | 2.27M |
| Venus Concept | 2.26M |
| Phio Pharmaceuticals | 2.20M |
| Xylo Technologies | 2.16M |
| Scorpius Holdings | 2.14M |
| Biodexa Pharmaceuticals | 2.09M |
| Salarius Pharmaceuticals | 2.03M |
| GRI Bio | 2.01M |